OMX Nordic 40
2.534,30
PKT
-0,06
PKT
±0,00
%
Werbung
Analysen zu OMX Nordic 40-Werten
Datum | Rating | Analyst | |
---|---|---|---|
03.01.25 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
02.01.25 | A.P. Moeller - Maersk A-S (B) Underperform | Bernstein Research | |
23.12.24 | Novo Nordisk Overweight | Barclays Capital | |
23.12.24 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
23.12.24 | Novo Nordisk Halten | DZ BANK | |
20.12.24 | Novo Nordisk Underperform | Bernstein Research | |
20.12.24 | Novo Nordisk Neutral | UBS AG | |
20.12.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
19.12.24 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
19.12.24 | ABB (Asea Brown Boveri) Market-Perform | Bernstein Research | |
17.12.24 | Novo Nordisk Buy | Deutsche Bank AG | |
17.12.24 | AstraZeneca Hold | Deutsche Bank AG | |
16.12.24 | Novo Nordisk Neutral | UBS AG | |
16.12.24 | Volvo (B) Buy | Deutsche Bank AG | |
16.12.24 | AstraZeneca Hold | Deutsche Bank AG | |
16.12.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
13.12.24 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
12.12.24 | Novo Nordisk Buy | Deutsche Bank AG | |
10.12.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
10.12.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
09.12.24 | Novo Nordisk Neutral | UBS AG | |
09.12.24 | Novo Nordisk Underperform | Bernstein Research | |
09.12.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
09.12.24 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | JP Morgan Chase & Co. | |
09.12.24 | Nokia Overweight | JP Morgan Chase & Co. | |
06.12.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
05.12.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
04.12.24 | Novo Nordisk Underperform | Bernstein Research | |
04.12.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
04.12.24 | A.P. Moeller - Maersk A-S (B) Underweight | JP Morgan Chase & Co. | |
04.12.24 | ABB (Asea Brown Boveri) Underweight | Barclays Capital | |
03.12.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
03.12.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
02.12.24 | Hennes Mauritz (H M, H&M) Buy | UBS AG | |
02.12.24 | Novo Nordisk Neutral | UBS AG | |
01.12.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
28.11.24 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
27.11.24 | Novo Nordisk Buy | Deutsche Bank AG | |
27.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
27.11.24 | Volvo (B) Overweight | JP Morgan Chase & Co. |